Author:
Boye Kristina S.,Matza Louis S.,Walter Kimberly N.,Van Brunt Kate,Palsgrove Andrew C.,Tynan Aodan
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference79 articles.
1. Arulmozhi, D.K., Portha, B.: GLP-1 based therapy for type 2 diabetes. Eur. J. Pharm. Sci. 28, 96–108 (2006)
2. Pratley, R.E., Gilbert, M.: Targeting incretins in type 2 diabetes: role of GLP-1 receptor agonists and DPP-4 inhibitors. Rev. Diabet. Stud. 5, 73–94 (2008)
3. Srinivasan, B.T., Jarvis, J., Khunti, K., Davies, M.J.: Recent advances in the management of type 2 diabetes mellitus: a review. Postgrad. Med. J. 84, 524–531 (2008)
4. Torrance, G.W.: Measurement of health state utilities for economic appraisal. J. Health Econ. 5, 1–30 (1986)
5. Torrance, G.W.: Designing and conducting cost-utility analysis. In: Spilker, B. (eds.) Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven, Philadelphia (1996)
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献